IRME · As filed with the SEC

IR-Med balance sheet, by fiscal year

The statement as IR-Med presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021
Assets
Current assets
Cash and Cash Equivalents	129	767	3,002	2,815
Accounts Receivable	76	81	55	67
Total current assets	205	848	3,057	2,882
Long term deposits	—	—	—	30
Long term restricted deposits	—	11	11	—
Long-Term Investments	11	—	—	—
Operating Lease Right-of-Use Asset	—	84	155	—
Property, Plant and Equipment	35	56	71	31
Total non-current assets	46	151	237	61
Total assets	251	999	3,294	2,943
Liabilities and stockholders’ equity (deficit)
Accounts Payable	388	473	500	395
Stockholders’ loans	—	—	162	—
Short-Term Debt	157	—	—	—
Total current liabilities	545	473	662	—
Long-Term Debt	—	—	40	—
Stockholders’ loans	—	—	—	177
Stockholders’ loans	—	161	—	—
Total non-current liabilities	—	161	40	—
Total liabilities	545	634	702	572
Stockholders’ equity (deficit)
Total Stockholders' Equity	70	69	68	64
Additional Paid-In Capital	16,374	15,135	12,454	7,503
Retained Earnings	(16,738)	(14,839)	(9,930)	(5,196)
Total stockholders’ equity (deficit)	(294)	365	2,592	2,371
Total liabilities and stockholders’ equity	251	999	3,294	2,943

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.